Lionheart Health, Inc. has announced a strategic partnership with CoreViva to provide AI-enhanced full body MRI scans to participants in its Lionheart Klotho Wellness Program. This collaboration comes as Lionheart Health advances as a semi-finalist in the $101 million Xprize Healthspan competition, where it is testing a protocol designed to elevate circulating klotho levels through a comprehensive approach including klotho-promoting meals, daily supplements, and bioelectric klotho-enhanced exercise.
The integration of CoreViva's FDA-cleared AI technology will serve as a critical baseline measurement for patients entering the program, with follow-up scans scheduled at 12 months to track progress. Dr. Leslie Miller, Chief Medical Officer for Lionheart Health, emphasized the importance of this technology: "Launching our patients into the Lionheart Klotho Wellness Program with the CoreViva advanced AI analysis whole body MRI will give us a great baseline on their current health status, and we will run through again at 12 months. We are out to prove in our studies improvement of muscle health, cardiovascular health including calcification reduction, immunity health and brain health and this AI MRI will help us track progress."
CoreViva's mission to improve early disease detection through advanced imaging technology aligns with Lionheart Health's focus on healthspan longevity. The partnership represents a significant advancement in preventive medicine, combining cutting-edge imaging with targeted therapeutic interventions. The optional therapies available to participants include hyperbaric oxygen, red light therapy, infrared sauna, ozone treatment, PEMF, and various health-focused treatments addressing muscle toning, sexual health, joint health, brain health, skin health, breathing health, sleep health, stress management, inflammation reduction, blood pressure management, gut health, nature therapy, and vision and hearing health.
This collaboration marks an important step in validating klotho-based interventions through objective, AI-powered medical imaging, potentially setting new standards for measuring healthspan improvements in longevity research. The partnership leverages CoreViva's FDA-cleared technology available at https://coreviva.com to provide comprehensive health assessments that go beyond traditional metrics. By establishing detailed baseline measurements and tracking changes over time, the program aims to demonstrate tangible improvements across multiple health domains, from cardiovascular and brain health to immunity and muscle function.
The significance of this partnership extends beyond the immediate participants in the Lionheart Klotho Wellness Program. As Lionheart Health progresses in the Xprize Healthspan competition, the data collected through these AI-enhanced MRI scans could provide valuable insights into the effectiveness of klotho-based interventions for extending healthspan. The objective measurements obtained through CoreViva's technology offer a more comprehensive view of health improvements than traditional biomarkers alone, potentially revolutionizing how longevity interventions are evaluated and validated in clinical research settings.
